Clinuvel Pharmaceuticals Limited ( CLVLF) - Stock Earnings
CLVLF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 1, 2026, midnight | — / — | — | — / — | — |
CLVLF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | 8.7 million USD | 22.2 million USD |
| 2025Q2 | 14.5 million USD | 39.0 million USD |
| 2025Q4 | 7.0 million USD | 24.7 million USD |
CLVLF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 20.3 million USD | 52.0 million USD |
| 2024 | 23.8 million USD | 58.8 million USD |
| 2025 | 23.8 million USD | 62.5 million USD |
CLVLF
Price: $7.27
Dividend Yield: 0.50%
Forward Dividend Yield: 0.90%
Payout Ratio: 7.08%
Dividend Per Share: 0.07 USD
Earnings Per Share: 0.46 USD
P/E Ratio: 18.13
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 329.7 million
Average Dividend Frequency: 2
Years Paying Dividends: 8
DGR3: 30.00%
DGR5: 30.00%